Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-10

Clinical Trial Update: Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans [Phase 2]

View source ↗

Summary

This report notes that a Phase 2 trial investigating novel estrogens for effects on glucose and lipid measures in postmenopausal prediabetic women veterans has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel estrogens

Snippet

Sponsor: VA Office of Research and Development | Conditions: Menopause, Prediabetes | Phase 2 | Status: WITHDRAWN